Norman C. Moore

1.7k total citations · 1 hit paper
30 papers, 1.3k citations indexed

About

Norman C. Moore is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Experimental and Cognitive Psychology. According to data from OpenAlex, Norman C. Moore has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Experimental and Cognitive Psychology. Recurrent topics in Norman C. Moore's work include Schizophrenia research and treatment (7 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Bipolar Disorder and Treatment (4 papers). Norman C. Moore is often cited by papers focused on Schizophrenia research and treatment (7 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Bipolar Disorder and Treatment (4 papers). Norman C. Moore collaborates with scholars based in United States, United Kingdom and Czechia. Norman C. Moore's co-authors include Samuel Gershon, C. Manegold, Joachim von Pawel, Martin Reck, Venice Archer, V. Gorbounova, Petr Zatloukal, N. B. Leighl, Rodryg Ramlau and J. Mezger and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Norman C. Moore

30 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

2010 498 citations Martin Reck, Joachim von Pawel et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norman C. Moore United States	15	388	350	320	297	215	30	1.3k
Yi Liao China	17	210 0.5×	188 0.5×	520 1.6×	208 0.7×	272 1.3×	42	1.5k
E. Klieser Austria	24	155 0.4×	415 1.2×	103 0.3×	323 1.1×	356 1.7×	91	1.6k
A. Steingart Canada	13	215 0.6×	108 0.3×	114 0.4×	557 1.9×	101 0.5×	15	1.2k
Barbara Schäuble Germany	23	131 0.3×	322 0.9×	271 0.8×	884 3.0×	458 2.1×	75	2.1k
Peter Mulders Netherlands	20	706 1.8×	438 1.3×	849 2.7×	203 0.7×	418 1.9×	64	2.3k
P. Decker Germany	18	449 1.2×	352 1.0×	500 1.6×	743 2.5×	450 2.1×	51	1.9k
Yu‐Chiau Shyu Taiwan	22	113 0.3×	173 0.5×	141 0.4×	264 0.9×	604 2.8×	76	1.6k
Jenna Collins United States	14	261 0.7×	113 0.3×	77 0.2×	302 1.0×	278 1.3×	33	1.7k
Ke Xu China	23	157 0.4×	210 0.6×	310 1.0×	100 0.3×	318 1.5×	73	1.3k

Countries citing papers authored by Norman C. Moore

Since Specialization

Citations

This map shows the geographic impact of Norman C. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman C. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman C. Moore more than expected).

Fields of papers citing papers by Norman C. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman C. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman C. Moore. The network helps show where Norman C. Moore may publish in the future.

Co-authorship network of co-authors of Norman C. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Norman C. Moore. A scholar is included among the top collaborators of Norman C. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman C. Moore. Norman C. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Birur, Badari, Norman C. Moore, & Lori L. Davis. (2016). An Evidence-Based Review of Early Intervention and Prevention of Posttraumatic Stress Disorder. Community Mental Health Journal. 53(2). 183–201. 46 indexed citations

Reck, Martin, Joachim von Pawel, Petr Zatloukal, et al.. (2010). Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL). Annals of Oncology. 21(9). 1804–1809. 498 indexed citations breakdown →

Lauterbach, E. C., et al.. (2001). Tardive Dyskinesia--Diagnostic Issues, Subsyndromes, and Concurrent Movement Disorders: A Study of State Hospital Inpatients Referred to a Movement Disorder Consultation Service. Schizophrenia Bulletin. 27(4). 601–613. 8 indexed citations

Lane, Joshua, et al.. (2000). Screening for depression within a rural primary care practice by a self-rating depression scale. 6(2). 73–76. 1 indexed citations

Coburn, Kerry L., et al.. (1998). P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication. Biological Psychiatry. 44(6). 466–474. 72 indexed citations

Moore, Norman C., et al.. (1998). Five Papers on Psychiatry in Rural Areas: An Introduction. Psychiatric Services. 49(7). 957–957. 2 indexed citations

Moore, Norman C., et al.. (1997). Positive Symptoms of Schizophrenia: Response to Haloperidol and Remoxipride is Associated with Increased Alpha EEG Activity. Human Psychopharmacology Clinical and Experimental. 12(1). 75–80. 8 indexed citations

Moore, Norman C., et al.. (1996). P2 Flash Visual Evoked Response Delay May Be a Marker of Cognitive Dysfunction in Healthy Elderly Volunteers. International Psychogeriatrics. 8(4). 549–559. 6 indexed citations

Karson, Craig N., W. Sue T. Griffin, Robert E. Mrak, et al.. (1996). Nitric oxide synthase (NOS) in schizophrenia. Molecular and Chemical Neuropathology. 27(3). 275–284. 64 indexed citations

10.

Özsancak, Canan, et al.. (1996). Clozapine for the treatment of psychosis in Parkinson's disease: a review. Acta Neurologica Scandinavica. 94(5). 329–336. 19 indexed citations

11.

Moore, Norman C., et al.. (1995). Flash P2 delay in primary degenerative dementia of the Alzheimer type. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 19(3). 403–410. 14 indexed citations

12.

Pritchard, Walter S., Dennis W. Duke, Kerry L. Coburn, et al.. (1994). EEG-based, neural-net predictive classification of Alzheimer's disease versus control subjects is augmented by non-linear EEG measures. Electroencephalography and Clinical Neurophysiology. 91(2). 118–130. 140 indexed citations

13.

Coburn, Kerry L., et al.. (1992). HIV and the brain: Evidence of early involvement and progressive damage. Neuroreport. 3(6). 539–541. 12 indexed citations

14.

Moore, Norman C., et al.. (1992). FLASH P2 DELAY IS A PROBABLE BIOLOGICAL MARKER OF PRIMARY DEGENERATIVE DEMENTIA OF THE ALZHEIMER TYPE.. Clinical Neuropharmacology. 15. 291B–291B. 2 indexed citations

15.

Moore, Norman C. & Samuel Gershon. (1990). The Brain Renin-Angiotensin System and Behavior. Dementia and Geriatric Cognitive Disorders. 1(4). 225–236. 14 indexed citations

16.

Moore, Norman C. & Samuel Gershon. (1989). Which Atypical Antipsychotics Are Identified by Screening Tests?. Clinical Neuropharmacology. 12(3). 167–184. 23 indexed citations

17.

Moore, Norman C., et al.. (1987). Tiaspirone in Schizophrenia. Journal of Clinical Psychopharmacology. 7(2). 98???100–98???100. 11 indexed citations

18.

Moore, Norman C., et al.. (1987). A Controlled Clinical Trial of Tiaspirone in Schizophrenia. International Clinical Psychopharmacology. 2(2). 129–133. 8 indexed citations

19.

Lerer, Bernard, et al.. (1987). Carbamazepine versus lithium in mania: a double-blind study.. PubMed. 48(3). 89–93. 100 indexed citations

20.

Moore, Norman C.. (1974). Psychiatric Illness and Living in Flats. The British Journal of Psychiatry. 125(588). 500–507. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact